home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Constraining Neutrophil Damage

  July, 10 2008 8:28
your information resource in human molecular genetics
The way in which neutrophils -- the immune system's 'first responders' -- migrate into target tissues is reported online in Nature Immunology.

Neutrophils are the 'look-out' white blood cells that can exit the bloodstream at the first sign of infection and travel to its source. Here they can release their payload of noxious chemicals in an attempt to stave off the invaders.

Jingsong Xu and colleagues identify an intracellular signaling molecule, called MYLK, that is required for neutrophil movement. MYLK links the 'danger' signals sensed outside cells to their intracellular structure, allowing them to change shape and direction, as well as increasing their 'adhesive' properties needed to crawl through blood vessels.

Xu's group shows MYLK-deficient neutrophils are less able to enter lung tissues in response to septic infections. However, this defect is not a bad thing as neutrophil-mediated collateral damage is the leading cause of acute respiratory distress syndrome (ARDS), a potential lethal complication of sepsis-induced lung injury. By identifying the signaling pathway between MYLK and the cell structure, scientists can start to develop potential new targets for treating ARDS.

Author contact:

Jingsong Xu (University of Illinois College of Medicine, Chicago, IL, USA)
E-mail: Jingsong@uic.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.